globalbarry. Company Intelligence Engine

Apimeds Pharmaceuticals US, Inc.

APUS CIK 0001894525 · Pharmaceutical Preparations (SIC 2834)

Disclosed SEC business address
100 MATAWAN RD, SUITE 325, MATAWAN, NJ, 07747

Apimeds Pharmaceuticals US, Inc. (ticker APUS, CIK 0001894525) is tracked by Global Barry from its public SEC filings and disclosures. Disclosed industry classification: Pharmaceutical Preparations (SIC 2834). Disclosed business address country: United States. Every item is grounded on the cited public source — no figures are fabricated.

63 exposure relationships mapped 52 related entities (events · industries · countries) Intelligence last refreshed 2026-11-04

Top findings public preview

  • FACT Disclosed industry: Pharmaceutical Preparations (SIC 2834)
  • FACT Country of disclosed business address: United States
  • FACT 8-K filed (period 2026-10-04) 2026-10-13 source ↗

You've reached this month's free company deep views

The public preview above stays free and available. To open the deeper, source-linked evidence detail — and the full in-app workspace — sign up free or upgrade your plan. Higher plans include more (or unlimited) deep views each month.

Bringing your own AI key (BYOK) raises only your AI analysis cap — it does not raise the company deep-view cap.

Sources

Grounded on public SEC filings and disclosures with explicit evidence tiers and citations. This page is informational only and is not investment advice. No figures are fabricated; unavailable data is shown as unavailable.